CD8A and neoplasm: The inability of this cellular immune response to control melanoma tumor sites in the brain despite concurrent eradication of distant flank tumor sites could result from differences in the magnitude of immune response, as we observed significantly fewer CD8+ T cells and a decreased ratio of effector CD8+: suppressor Tregs in intracranial melanomas.